Browse > Article

Signal Transduction Network Leading to COX-2 Induction: A Road Map in Search of Cancer Chemopreventives  

Surh Young-Joon (National Research Laboratory of Molecular Carcinogenesis and Chemoprevention, College of Pharmacy, Seoul National University)
Kundu Joydeb Kumar (National Research Laboratory of Molecular Carcinogenesis and Chemoprevention, College of Pharmacy, Seoul National University)
Publication Information
Archives of Pharmacal Research / v.28, no.1, 2005 , pp. 1-15 More about this Journal
Abstract
Cancer is still a major global health concern even after an everlasting strive in conquering this dread disease. Emphasis is now given to chemoprevention to reduce the risk of cancer and also to improve the quality of life among cancer afflicted individuals. Recent progress in molecular biology of cancer has identified key components of the cellular signaling network, whose functional abnormality results in undesired alterations in cellular homeostasis, creating a cellular microenvironment that favors premalignant and malignant transformation. Multiple lines of evidence suggest an elevated expression of cyclooxygenase-2 (COX-2) is causally linked to cancer. In response to oxidative/pro-inflammatory stimuli, turning on unusual signaling arrays mediated through diverse classes of kinases and transcription factors results in aberrant expression of COX-2. Population-based as well as laboratory studies have explored a broad spectrum of chemopreventive agents including selective COX-2 inhibitors and a wide variety of anti-inflammatory phytochemicals, which have been shown to target cellular signaling molecules as underlying mechanisms of chemoprevention. Thus, unraveling signaling pathways regulating aberrant COX-2 expression and targeted blocking of one or more components of those signal cascades may be exploited in searching chemopreventive agents in the future.
Keywords
Chemoprevention; Cyclooxygenase-2; MAPKs; Pl3K-Akt; NF-kB; AP-1; Signaling network; NSAIDs; Antiinflammatory phytochemicals;
Citations & Related Records

Times Cited By Web Of Science : 21  (Related Records In Web of Science)
Times Cited By SCOPUS : 20
연도 인용수 순위
1 Allport, V. C., Slater, D. M., Newton, R., and Bennett, P. R., NF- ${\kappa}B$ and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol. Hum. Reprod., 6, 561-565 (2000)   DOI   ScienceOn
2 Alshafie, G. A., Abou-Issa, H. M., Seibert, K., and Harris, R. E., Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase- 2 inhibitor, in a rat mammary tumor model. Oncol. Rep., 7, 1377-1381 (2000)
3 Baldwin, A. S., Jr., The NF-${\kappa}$B and I${\kappa}$B proteins: new discoveries and insights. Annu. Rev. Immunol., 14, 649-683 (1996)   DOI   PUBMED   ScienceOn
4 Banerjee, S., Bueso-Ramos, C., and Aggarwal, B. B., Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factorkappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res., 62, 4945-4954 (2002)
5 Bennett, A., The production of prostanoids in human cancers, and their implications for tumor progression. Prog. Lipid Res., 25, 539-542 (1986)   DOI   PUBMED   ScienceOn
6 Bird, T. A., Schooley, K., Dower, S. K., Hagen, H., and Virca, G. D., Activation of nuclear transcription factor NF-${\kappa}$B by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit. J. Biol. Chem., 272, 32606-32612 (1997)   DOI   ScienceOn
7 Bode, A. M., Ma, W. Y., Surh, Y.-J., and Dong, Z., Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res., 61, 850-853 (2001)
8 Caivano, M. and Cohen, P., Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1${\beta}$ in RAW264 macrophages. J. Immunol., 164, 3018-3025 (2000)
9 Chun, K.-S., Kang, J.-Y., Kim, O.-H., Kang, H., and Surh, Y.-J., Effects of yakuchinone A and yakuchinone B on the phorbol ester-induced expression of COX-2 and iNOS and activation of NF-${\kappa}$B in mouse skin. J. Environ. Pathol. Toxicol. Oncol., 21, 131-139 (2002a)
10 Clevers, H., At the crossroads of inflammation and cancer. Cell, 118, 671-674 (2004)   DOI   PUBMED   ScienceOn
11 Conney, A. H., Lou, Y. R., Xie, J. G., Osawa, T., Newmark, H. L., Liu, Y., Chang, R. L., and Huang, M. T., Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea. Proc. Soc. Exp. Biol. Med., 216, 234-245 (1997)
12 Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z. W., Egan, L. J., Kagnoff, M. F., and Karin, M., IKK${\beta}$ links inflammation and tumorigenesis in a mouse model of colitisassociated cancer. Cell, 118, 285-296 (2004)   DOI   PUBMED   ScienceOn
13 Harnish, D. C., Scicchitano, M. S., Adelman, S. J., Lyttle, C. R., and Karathanasis, S. K., The role of CBP in estrogen receptor cross-talk with nuclear factor-${\kappa}$B in HepG2 cells. Endocrinology, 141, 3403-3411 (2000)   DOI   ScienceOn
14 Kikuchi, T., Itoh, F., Toyota, M., Suzuki, H., Yamamoto, H., Fujita, M., Hosokawa, M., and Imai, K., Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer. Int. J. Cancer, 97, 272-277 (2002)   DOI   ScienceOn
15 Imbert, V., Rupec, R. A., Livolsi, A., Pahl, H. L., Traenckner, E. B., Mueller-Dieckmann, C., Farahifar, D., Rossi, B., Auberger, P., Baeuerle, P. A., and Peyron, J. F., Tyrosine phosphorylation of I${\kappa}$B-${\alpha}$ activates NF-${\kappa}$B without proteolytic degradation of I${\kappa}$B-${\alpha}$. Cell, 86, 787-798 (1996)   DOI   PUBMED   ScienceOn
16 Itzkowitz, S. H. and Yio, X., Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol., 287, G7-17 (2004)   DOI   ScienceOn
17 Kawamori, T., Rao, C. V., Seibert, K., and Reddy, B. S., Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58, 409-412 (1998)
18 Kim, S.O., Chun, K.-S., Kundu, J., and Surh, Y.-J., Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-${\kappa}$B and p38 MAPK in mouse skin. Biofactors, 21, 27-31 (2004)   DOI   ScienceOn
19 Kojima, M., Morisaki, T., Izuhara, K., Uchiyama, A., Matsunari, Y., Katano, M., and Tanaka, M., Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-${\kappa}$B activation. Oncogene, 19, 1225- 1231 (2000)   DOI   ScienceOn
20 Koong, A. C., Chen, E. Y., Mivechi, N. F., Denko, N. C., Stambrook, P., and Giaccia, A. J., Hypoxic activation of nuclear factor-${\kappa}$B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res., 54, 5273-5279 (1994)
21 Kosaka, T., Miyata, A., Ihara, H., Hara, S., Sugimoto, T., Takeda, O., Takahashi, E., and Tanabe, T., Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur. J. Biochem., 221, 889-897 (1994)   DOI   ScienceOn
22 Kundu, J. K., Chun, K.-S., Kim, S. O., and Surh, Y.-J., Resveratrol inhibits phorbol ester-induced cyclooxygenase-2 expression in mouse skin: MAPKs and AP-1 as potential molecular targets. Biofactors, 21, 33-39 (2004)   DOI   PUBMED
23 Kundu, J. K., Na, H.-K., Chun, K.-S., Kim, Y.-K., Lee, S. J., Lee, S. S., Lee, O.-S., Sim, Y.-C., and Surh, Y.-J., Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. J. Nutr., 133, 3805S-3810S (2003)
24 Leung, W. K., To, K. F., Ng, Y. P., Lee, T. L., Lau, J. Y., Chan, F. K., Ng, E. K., Chung, S. C., and Sung, J. J., Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer. Br. J. Cancer, 84, 335-339 (2001)   DOI   ScienceOn
25 Li, Z. G., Shimada, Y., Sato, F., Maeda, M., Itami, A., Kaganoi, J., Komoto, I., Kawabe, A., and Imamura, M., Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamineinduced esophageal tumorigenesis in F344 rats. Int. J. Oncol., 21, 1275-1283 (2002)
26 Niederberger, E., Tegeder, I., Vetter, G., Schmidtko, A., Schmidt, H., Euchenhofer, C., Brautigam, L., Grosch, S., and Geisslinger, G., Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-${\kappa}$B. FASEB J., 15, 1622-1624 (2001)
27 Madrid, L. V., Mayo, M. W., Reuther, J. Y., and Baldwin, A. S., Jr., Akt stimulates the transactivation potential of the RelA/ p65 Subunit of NF-${\kappa}$B through utilization of the I${\kappa}$B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem., 276, 18934-18940 (2001)   DOI   ScienceOn
28 Molina-Holgado, E., Ortiz, S., Molina-Holgado, F., and Guaza, C., Induction of COX-2 and $PGE_{2}$ biosynthesis by IL-1${\beta}$ is mediated by PKC and mitogen-activated protein kinases in murine astrocytes. Br. J. Pharmacol., 131, 152-159 (2000)   DOI   PUBMED   ScienceOn
29 Murakami, A., Matsumoto, K., Koshimizu, K., and Ohigashi, H., Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferongamma- induced I${\kappa}$B degradation in RAW264.7 macrophages. Cancer Lett., 195, 17-25 (2003)   DOI   ScienceOn
30 Park, K. K., Chun, K.-S., Lee, J.-M., Lee, S. S., and Surh, Y.-J., Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett., 129, 139-144 (1998)   DOI   ScienceOn
31 Park, O.-J. and Surh, Y.-J., Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol. Lett., 150, 43-56 (2004)   DOI   ScienceOn
32 Shishodia, S., Potdar, P., Gairola, C. G., and Aggarwal, B. B., Curcumin (diferuloylmethane) down-regulates cigarette smokeinduced NF-${\kappa}$B activation through inhibition of I${\kappa}$B${\alpha}$ kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis, 24, 1269- 1279 (2003)   DOI   ScienceOn
33 Pentland, A. P., Schoggins, J. W., Scott, G. A., Khan, K. N., and Han, R., Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis, 20, 1939-1944 (1999)   DOI   ScienceOn
34 Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., and Ben-Neriah, Y., NF-${\kappa}$B functions as a tumour promoter in inflammation-associated cancer. Nature, 431, 461-466 (2004)   DOI   PUBMED   ScienceOn
35 Schreinemachers, D. M. and Everson, R. B., Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology, 5, 138-146 (1994)   DOI
36 Steinbach, G., Lynch, P. M., Phillips, R. K., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., Su, L. K., and Levin, B., The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med., 342, 1946-1952 (2000)   DOI   ScienceOn
37 Subbaramaiah, K., Altorki, N., Chung, W. J., Mestre, J. R., Sampat, A., and Dannenberg, A. J., Inhibition of cyclooxygenase- 2 gene expression by p53. J. Biol. Chem., 274, 10911-10915 (1999)   DOI   ScienceOn
38 Takeda, K., Kanekura, T., and Kanzaki, T., Negative feedback regulation of phosphatidylinositol 3-kinase/Akt pathway by over-expressed cyclooxygenase-2 in human epidermal cancer cells. J. Dermatol., 31, 516-523 (2004)
39 Surh, Y.-J., Lee, R. C., Park, K.-K., Mayne, S. T., Liem, A., and Miller, J. A., Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis or tumorigenesis by vinyl carbamate and N-nitrosodimethylamine. Carcinogenesis, 16, 2467-2471 (1995)   DOI   ScienceOn
40 Surh, Y.-J. and Lee, S.-S., Capsaicin, a double-edged sword: toxicity, metabolism, and chemopreventive potential. Life Sci., 56, 1845-1855 (1995)   DOI   ScienceOn
41 Wang, H. Q., Kim, M. P., Tiano, H. F., Langenbach, R., and Smart, R. C., Protein kinase C-alpha coordinately regulates cytosolic phospholipase $A_{2}$ activity and the expression of cyclooxygenase-2 through different mechanisms in mouse keratinocytes. Mol. Pharmacol., 59, 860-866 (2001)
42 Wong, B. C., Jiang, X., Fan, X. M., Lin, M. C., Jiang, S. H., Lam, S. K., and Kung, H. F., Suppression of RelA/p65 nuclear translocation independent of I${\kappa}$B-${\alpha}$ degradation by cyclooxygenase- 2 inhibitor in gastric cancer. Oncogene, 22, 1189- 1197 (2003)   DOI   ScienceOn
43 Yan, X., Wu Xiao, C., Sun, M., Tsang, B. K., and Gibb, W., Nuclear factor ${\kappa}$B activation and regulation of cyclooxygenase type-2 expression in human amnion mesenchymal cells by interleukin-1${\beta}$. Biol. Reprod., 66, 1667-1671 (2002)   DOI   ScienceOn
44 Yang, F., Tang, E., Guan, K., and Wang, C. Y., IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J. Immunol., 170, 5630-5635 (2003)
45 Miller, C., Zhang, M., He, Y., Zhao, J., Pelletier, J. P., Martel- Pelletier, J., and Di Battista, J. A., Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins. J. Cell. Biochem., 69, 392-413 (1998)   DOI   ScienceOn
46 Chan, G., Boyle, J. O., Yang, E. K., Zhang, F., Sacks, P. G., Shah, J. P., Edelstein, D., Soslow, R. A., Koki, A. T., Woerner, B. M., Masferrer, J. L., and Dannenberg, A. J., Cyclooxygenase- 2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res., 59, 991-994 (1999)
47 Aziz, M., Afaq, F., and Ahmad, N., Prevention of ultraviolet B radiation-damage by resveratrol in mouse skin is mediated via modulation in Survivin. Photochem. Photobiol., in press (2004)
48 Bird, A. P. and Wolffe, A. P., Methylation-induced repression-- belts, braces, and chromatin. Cell, 99, 451-454 (1999)   DOI   ScienceOn
49 Chun, K.-S., Keum, Y.-S., Han, S.-S., Song, Y.-S., Kim, S.-H., and Surh, Y.-J., Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-${\kappa}$B activation. Carcinogenesis, 24, 1515-1524 (2003)   DOI   ScienceOn
50 Martinez, J. and Moreno, J. J., Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol., 59, 865-870 (2000)   DOI   PUBMED   ScienceOn
51 Sheng, H., Shao, J., and Dubois, R. N., K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Cancer Res., 61, 2670- 2675 (2001)
52 Marks, F., Muller-Decker, K., and Furstenberger, G., A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism. Toxicology, 153, 11-26 (2000)   DOI   PUBMED   ScienceOn
53 Shao, J., Sheng, H., Inoue, H., Morrow, J. D., and DuBois, R. N., Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J. Biol. Chem., 275, 33951-33956 (2000)   DOI   ScienceOn
54 Wang, D. and Baldwin, A. S., Jr., Activation of nuclear factorkappaB- dependent transcription by tumor necrosis factoralpha is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol. Chem., 273, 29411-29416 (1998)   DOI
55 Surh, Y.-J., Chun, K.-S., Cha, H.-H., Han, S.-S., Keum, Y.-S., Park, K.-K., and Lee, S.-S., Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-${\kappa}$B activation. Mutat. Res., 480-481, 243- 268 (2001)
56 Shishodia, S. and Aggarwal, B. B., Nuclear factor-${\kappa}$B: a friend or a foe in cancer? Biochem. Pharmacol., 68, 1071-1080 (2004)   DOI   ScienceOn
57 St-Germain, M. E., Gagnon, V., Mathieu, I., Parent, S., and Asselin, E., Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. Int. J. Oncol., 24, 1311-1324 (2004a)
58 Aggarwal, S., Takada, Y., Singh, S., Myers, J. N., and Aggarwal, B. B., Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-${\kappa}$B signaling. Int. J. Cancer, 111, 679-692 (2004b)   DOI   ScienceOn
59 Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., and Speizer, F. E., Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med., 333, 609-614 (1995)   DOI   ScienceOn
60 Huang, M. T., Newmark, H. L., and Frenkel, K., Inhibitory effects of curcumin on tumorigenesis in mice. J. Cell Biochem. Suppl., 27, 26-34 (1997)   DOI
61 Wang, X., Martindale, J. L., Liu, Y., and Holbrook, N. J., The cellular response to oxidative stress: influences of mitogenactivated protein kinase signalling pathways on cell survival. Biochem. J., 333 ( Pt 2), 291-300 (1998)
62 Wu, K. K., Aspirin and other cyclooxygenase inhibitors: new therapeutic insights. Semin. Vasc. Med., 3, 107-112 (2003)   DOI   PUBMED   ScienceOn
63 Martin, A. R., Villegas, I., La Casa, C., and de la Lastra, C. A., Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem. Pharmacol., 67, 1399- 1410 (2004)   DOI   ScienceOn
64 Surh, Y.-J. and Lee, S.-S., Capsaicin in hot chili pepper: carcinogen, co-carcinogen or anticarcinogen? Food Chem. Toxicol., 34, 313-316 (1996)   DOI   ScienceOn
65 Surh, Y.-J., Na, H.-K., and Lee, S.-S., Transcription factors and mitogen-activated protein kinases as molecular targets for chemoprevention with anti-inflammatory phytochemicals. Biofactors, 21, 103-108 (2004)   DOI   PUBMED
66 Fischer, S. M., Lo, H. H., Gordon, G. B., Seibert, K., Kelloff, G., Lubet, R. A., and Conti, C. J., Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol. Carcinog., 25, 231-240 (1999)   DOI   ScienceOn
67 Guan, Z., Buckman, S. Y., Miller, B. W., Springer, L. D., and Morrison, A. R., Interleukin-1$\beta$-induced cyclooxygenase-2 expression requires activation of both c-Jun $NH_2$-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J. Biol. Chem., 273, 28670-28676 (1998)   DOI
68 Liu, W., Reinmuth, N., Stoeltzing, O., Parikh, A. A., Tellez, C., Williams, S., Jung, Y. D., Fan, F., Takeda, A., Akagi, M., Bar- Eli, M., Gallick, G. E., and Ellis, L. M., Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways. Cancer Res., 63, 3632-3636 (2003)
69 Subbaramaiah, K., Norton, L., Gerald, W., and Dannenberg, A. J., Cyclooxygenase-2 is overexpressed in HER-2/neupositive breast cancer: evidence for involvement of AP-1 and PEA3. J. Biol. Chem., 277, 18649-18657 (2002)   DOI   ScienceOn
70 Kang, G., Kong, P. J., Yuh, Y. J., Lim, S. Y., Yim, S. V., Chun, W., and Kim, S. S., Curcumin suppresses lipopolysaccharideinduced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor ${\kappa}$B bindings in BV2 microglial cells. J. Pharmacol. Sci., 94, 325-328 (2004)   DOI   ScienceOn
71 Marx, J., Cancer research. Inflammation and cancer: the link grows stronger. Science, 306, 966-968 (2004)   DOI
72 Muller-Decker, K., Neufang, G., Berger, I., Neumann, M., Marks, F., and Furstenberger, G., Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc. Natl. Acad. Sci. USA, 99, 12483-12488 (2002)   DOI   ScienceOn
73 D'Acquisto, F., Iuvone, T., Rombola, L., Sautebin, L., Di Rosa, M. and Carnuccio, R., Involvement of NF-${\kappa}$B in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett., 418, 175-178 (1997)   DOI   PUBMED   ScienceOn
74 Ghosh, S. and Karin, M., Missing pieces in the NF-${\kappa}$B puzzle. Cell, 109, S81-S96 (2002)   DOI   ScienceOn
75 Gorgoni, B., Caivano, M., Arizmendi, C., and Poli, V., The transcription factor C/EBP${\beta}$ is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts. J. Biol. Chem., 276, 40769-40777 (2001)   DOI   ScienceOn
76 Han, S.-S., Keum, Y.-S., Seo, H.-J., Chun, K.-S., Lee, S.-S., and Surh, Y.-J., Capsaicin suppresses phorbol ester-induced activation of NF-${\kappa}$B/Rel and AP-1 transcription factors in mouse epidermis. Cancer Lett., 164, 119-126 (2001)   DOI   ScienceOn
77 Chun, K.-S., Park, K.-K., Lee, J., Kang, M., and Surh, Y.-J., Inhibition of mouse skin tumor promotion by antiinflammatory diarylheptanoids derived from Alpinia oxyphylla Miquel (Zingiberaceae). Oncol. Res., 13, 37-45 (2002b)
78 Grubbs, C. J., Lubet, R. A., Koki, A. T., Leahy, K. M., Masferrer, J. L., Steele, V. E., Kelloff, G. J., Hill, D. L., and Seibert, K., Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamineinduced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res., 60, 5599-5602 (2000)   PUBMED
79 Tjandrawinata, R. R. and Hughes-Fulford, M., Up-regulation of cyclooxygenase-2 by product-prostaglandin $E_2$. Adv. Exp. Med. Biol., 407, 163-170 (1997)
80 Vanderveen, E. E., Grekin, R. C., Swanson, N. A., and Kragballe, K., Arachidonic acid metabolites in cutaneous carcinomas. Evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth pattern. Arch. Dermatol., 122, 407-412 (1986)   DOI   ScienceOn
81 Li, L., Aggarwal, B. B., Shishodia, S., Abbruzzese, J., and Kurzrock, R., Nuclear factor-${\kappa}$B and I${\kappa}$B kinase are constitutively active in human pancreatic cells, and their downregulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer, 101, 2351-2362 (2004)   DOI   PUBMED   ScienceOn
82 Takahashi, N., Tetsuka, T., Uranishi, H., and Okamoto, T., Inhibition of the NF-${\kappa}$B transcriptional activity by protein kinase A. Eur. J. Biochem., 269, 4559-4565 (2002)   DOI   ScienceOn
83 Wilgus, T. A., Koki, A. T., Zweifel, B. S., Kusewitt, D. F., Rubal, P. A., and Oberyszyn, T. M., Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment. Mol. Carcinog., 38, 49-58 (2003)   DOI   ScienceOn
84 Callejas, N. A., Fernandez-Martinez, A., Castrillo, A., Bosca, L., and Martin-Sanz, P., Selective inhibitors of cyclooxygenase-2 delay the activation of nuclear factor${\kappa}$B and attenuate the expression of inflammatory genes in murine macrophages treated with lipopolysaccharide. Mol. Pharmacol., 63, 671- 677 (2003)   DOI   ScienceOn
85 Deak, M., Clifton, A. D., Lucocq, L. M., and Alessi, D. R., Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J., 17, 4426-4441 (1998)   DOI   ScienceOn
86 Hussain, T., Gupta, S., Adhami, V. M., and Mukhtar, H., Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int. J. Cancer, 113, 660-669 (2005)   DOI   ScienceOn
87 Liu, S. F., Ye, X., and Malik, A. B., Inhibition of NF-${\kappa}$B activation by pyrrolidine dithiocarbamate prevents in vivo expression of pro-inflammatory genes. Circulation, 100, 1330-1337 (1999)   DOI   ScienceOn
88 Chun, K. S., Kim, S. H., Song, Y. S., and Surh, Y. J., Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Carcinogenesis, 25, 713-722 (2004)   DOI   ScienceOn
89 Chun, K.-S. and Surh, Y.-J., Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol., 68, 1089-1100 (2004)   DOI   ScienceOn
90 Kim, C. S., Kawada, T., Kim, B. S., Han, I. S., Choe, S. Y., Kurata, T., and Yu, R., Capsaicin exhibits anti-inflammatory property by inhibiting $I{\kappa}B{\alpha}$ degradation in LPS-stimulated peritoneal macrophages. Cell Signal., 15, 299-306 (2003)   DOI   ScienceOn
91 Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. M., Suppression of intestinal polyposis in Apc $^{\delta716}$ knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809 (1996)   DOI   PUBMED   ScienceOn
92 Cui, Y., Kim, D. S., Park, S. H., Yoon, J. A., Kim, S. K., Kwon, S. B., and Park, K. C., Involvement of ERK and p38 MAP kinase in AAPH-induced COX-2 expression in HaCaT cells. Chem. Phys. Lipids, 129, 43-52 (2004)   DOI   ScienceOn
93 Akarasereenont, P. and Thiemermann, C., The induction of cyclo-oxygenase-2 in human pulmonary epithelial cell culture (A549) activated by IL-1${\beta}$ is inhibited by tyrosine kinase inhibitors. Biochem. Biophys. Res. Commun., 220, 181-185 (1996)   DOI   PUBMED   ScienceOn
94 Rigas, B., Goldman, I. S., and Levine, L., Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med., 122, 518- 523 (1993)
95 Yip-Schneider, M. T., Barnard, D. S., Billings, S. D., Cheng, L., Heilman, D. K., Lin, A., Marshall, S. J., Crowell, P. L., Marshall, M. S., and Sweeney, C. J., Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis, 21, 139-146 (2000)   DOI   ScienceOn
96 Verma, A. K., Ashendel, C. L., and Boutwell, R. K., Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-Otetradecanoylphorbol- 13-acetate. Cancer Res., 40, 308-315 (1980)
97 Xie, W. and Herschman, H. R., v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun Nterminal kinase and the c-Jun transcription factor. J. Biol. Chem., 270, 27622-27628 (1995)   DOI   ScienceOn
98 Zhou, W., Jiang, Z. W., Tian, J., Jiang, J., Li, N., and Li, J. S., Role of NF-${\kappa}$B and cytokine in experimental cancer cachexia. World. J. Gastroenterol., 9, 1567-1570 (2003)
99 Zweifel, B. S., Davis, T. W., Ornberg, R. L., and Masferrer, J. L., Direct evidence for a role of cyclooxygenase 2-derived prostaglandin $E_2$ in human head and neck xenograft tumors. Cancer Res., 62, 6706-6711 (2002)
100 Sheng, H., Williams, C. S., Shao, J., Liang, P., DuBois, R. N., and Beauchamp, R. D., Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J. Biol. Chem., 273, 22120-22127 (1998)   DOI   ScienceOn
101 Park, K. K. and Surh, Y.-J., Effects of capsaicin on chemicallyinduced two-stage mouse skin carcinogenesis. Cancer Lett., 114, 183-184 (1997)   DOI   ScienceOn
102 Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., and Collins, T., CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. U.S.A., 94, 2927- 2932 (1997)   DOI
103 Huang, W. C., Chen, J. J., Inoue, H., and Chen, C. C., Tyrosine phosphorylation of I${\kappa}$B kinase ${\alpha}$/${\beta}$ by protein kinase Cdependent c-Src activation is involved in TNF-${\alpha}$-induced cyclooxygenase-2 expression. J. Immunol., 170, 4767-4775 (2003)
104 Surh, Y.-J., Han, S.-S., Keum, Y.-S., Seo, H.-J., and Lee, S.-S., Inhibitory effects of curcumin and capsaicin on phorbol esterinduced activation of eukaryotic transcription factors, NF-${\kappa}$B and AP-1. Biofactors, 12, 107-112 (2000)   DOI   ScienceOn
105 Tang, Q., Gonzales, M., Inoue, H., and Bowden, G. T., Roles of Akt and glycogen synthase kinase 3beta in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes. Cancer Res., 61, 4329-4332 (2001)
106 Tsujii, M. and DuBois, R. N., Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501 (1995)   DOI   ScienceOn
107 Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., and Takada, Y., Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res., 24, 2783-2840 (2004a)
108 Akarasereenont, P., Mitchell, J. A., Appleton, I., Thiemermann, C., and Vane, J. R., Involvement of tyrosine kinase in the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cells. Br. J. Pharmacol., 113, 1522- 1528 (1994)   DOI   ScienceOn
109 Bortuzzo, C., Hanif, R., Kashfi, K., Staiano-Coico, L., Shiff, S. J., and Rigas, B., The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells. Biochim. Biophys. Acta, 1300, 240-246 (1996)   DOI   ScienceOn
110 Leahy, K. M., Ornberg, R. L., Wang, Y., Zweifel, B. S., Koki, A. T., and Masferrer, J. L., Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res., 62, 625-631 (2002)
111 Qiao, L., Kozoni, V., Tsioulias, G. J., Koutsos, M. I., Hanif, R., Shiff, S. J., and Rigas, B., Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim. Biophys. Acta, 1258, 215-223 (1995)   DOI   ScienceOn
112 Wesselborg, S., Bauer, M. K., Vogt, M., Schmitz, M. L., and Schulze-Osthoff, K., Activation of transcription factor NF-${\kappa}$B and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J. Biol. Chem., 272, 12422-12429 (1997)   DOI   ScienceOn
113 Evans, J. F., Rofecoxib (Vioxx), a specific cyclooxygenase-2 inhibitor, is chemopreventive in a mouse model of colon cancer. Am. J. Clin. Oncol., 26, S62-65 (2003)
114 Keum, Y.-S., Han, S.-S., Chun, K.-S., Park, K.-K., Park, J.-H., Lee, S.-K., and Surh, Y.-J., Inhibitory effects of the ginsenoside $Rg_3$ on phorbol ester-induced cyclooxygenase- 2 expression, NF-${\kappa}$B activation and tumor promotion. Mutat. Res., 523-524, 75-85 (2003)   DOI   ScienceOn
115 Lee, J.-Y., Shin, J.-W., Chun, K.-S., Park, K. K., Chung, W.-Y., Bang, Y.-J., Sung, J.-H., and Surh, Y.-J., Anti-tumor promotional effects of a novel intestinal bacterial metabolite (IH- 901) derived from the protopanaxadiol type ginsenosides in mouse skin. Carcinogenesis, in press
116 Sizemore, N., Leung, S., and Stark, G. R., Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-${\kappa}$B p65/ RelA subunit. Mol. Cell Biol., 19, 4798-4805 (1999)
117 Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., and Dannenberg, A. J., Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem., 273, 21875-21882 (1998)   DOI   ScienceOn
118 Tiano, H. F., Loftin, C. D., Akunda, J., Lee, C. A., Spalding, J., Sessoms, A., Dunson, D. B., Rogan, E. G., Morham, S. G., Smart, R. C., and Langenbach, R., Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res., 62, 3395-3401 (2002)
119 Zhong, H., Voll, R. E., and Ghosh, S., Phosphorylation of NF-${\kappa}$B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell, 1, 661-671 (1998)   DOI   ScienceOn
120 Giardiello, F. M., Offerhaus, G. J., and DuBois, R. N., The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Eur. J. Cancer, 31A, 1071-1076 (1995)   DOI   ScienceOn
121 St-Germain, M. E., Gagnon, V., Parent, S., and Asselin, E., Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-${\kappa}$B/I${\kappa}$B pathway. Mol. Cancer., 3, 7 (2004b)
122 Kundu, J. K. and Surh, Y.-J., Molecular basis of chemoprevention by resveratrol: NF-${\kappa}$B and AP-1 as potential targets. Mutat. Res., 555, 65-80 (2004)   DOI   ScienceOn
123 Shishodia, S., Koul, D., and Aggarwal, B. B., Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-${\kappa}$B activation through inhibition of activation of I${\kappa}$B${\alpha}$ kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. J. Immunol., 173, 2011- 2022 (2004)
124 Takada, Y., Mukhopadhyay, A., Kundu, G. C., Mahabeleshwar, G. H., Singh, S., and Aggarwal, B. B., Hydrogen peroxide activates NF-${\kappa}$B through tyrosine phosphorylation of I${\kappa}$B${\alpha}$ and serine phosphorylation of p65: evidence for the involvement of IkBa kinase and Syk protein-tyrosine kinase. J. Biol. Chem., 278, 24233-24241 (2003)   DOI   ScienceOn
125 Canty, T. G., Jr., Boyle, E. M., Jr., Farr, A., Morgan, E. N., Verrier, E. D., and Pohlman, T. H., Oxidative stress induces NF-${\kappa}$B nuclear translocation without degradation of I${\kappa}$B${\alpha}$. Circulation, 100, II361-364 (1999)   DOI   ScienceOn
126 Dannenberg, A. J., Altorki, N. K., Boyle, J. O., Dang, C., Howe, L. R., Weksler, B. B., and Subbaramaiah, K., Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol., 2, 544-551 (2001)   DOI   ScienceOn
127 Nugent, K. P., Farmer, K. C., Spigelman, A. D., Williams, C. B., and Phillips, R. K., Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br. J. Surg., 80, 1618-1619 (1993)   DOI   ScienceOn
128 Oshima, M., Murai, N., Kargman, S., Arguello, M., Luk, P., Kwong, E., Taketo, M. M., and Evans, J. F., Chemoprevention of intestinal polyposis in the $Apc^{\delta716}$ mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res., 61, 1733- 1740 (2001)
129 Sakurai, H., Chiba, H., Miyoshi, H., Sugita, T., and Toriumi, W., I${\kappa}$B kinases phosphorylate NF-${\kappa}$B p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem., 274, 30353- 30356 (1999)   DOI
130 Sheng, H., Shao, J., Dixon, D. A., Williams, C. S., Prescott, S. M., DuBois, R. N., and Beauchamp, R. D., Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J. Biol. Chem., 275, 6628-6635 (2000)   DOI   ScienceOn
131 Duvoix, A., Delhalle, S., Blasius, R., Schnekenburger, M., Morceau, F., Fougere, M., Henry, E., Galteau, M. M., Dicato, M., and Diederich, M., Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor ${\kappa}$B inhibition. Biochem. Pharmacol., 68, 1101-1111 (2004)   DOI   ScienceOn
132 Yucel-Lindberg, T., Ahola, H., Carlstedt-Duke, J., and Modeer, T., Involvement of tyrosine kinases on cyclooxygenase expression and prostaglandin $E_2$ production in human gingival fibroblasts stimulated with interleukin-1beta and epidermal growth factor. Biochem. Biophys. Res. Commun., 257, 528-532 (1999)   DOI   PUBMED   ScienceOn
133 Park, K. K., Chun, K.-S., Yook, J. I., and Surh, Y.-J., Lack of tumor promoting activity of capsaicin, a principal pungent ingredient of red pepper, in mouse skin carcinogenesis. Anticancer Res., 18, 4201-4205 (1998)
134 van Rees, B. P., Saukkonen, K., Ristimaki, A., Polkowski, W., Tytgat, G. N., Drillenburg, P., and Offerhaus, G. J., Cyclooxygenase- 2 expression during carcinogenesis in the human stomach. J. Pathol., 196, 171-179 (2002)   DOI   ScienceOn
135 Balkwill, F. and Mantovani, A., Inflammation and cancer: back to Virchow? Lancet, 357, 539-545 (2001)   DOI   ScienceOn
136 Chang, M. S., Chen, B. C., Yu, M. T., Sheu, J. R., Chen, T. F., and Lin, C. H., Phorbol 12-myristate 13-acetate upregulates cyclooxygenase-2 expression in human pulmonary epithelial cells via Ras, Raf-1, EPK, and NF-${\kappa}$B, but nop p38 MAPK, pathways. Cell Signal., 17, 299-310 (2005)   DOI   ScienceOn
137 Chen, C. C., Sun, Y. T., Chen, J. J., and Chiu, K. T., TNF-alphainduced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-${\gamma}$2, protein kinase C-${\alpha}$, tyrosine kinase, NF-${\kappa}$B-inducing kinase, and I${\kappa}$B kinase 1/2 pathway. J. Immunol., 165, 2719-2728 (2000)
138 Inoue, H., Yokoyama, C., Hara, S., Tone, Y., and Tanabe, T., Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J. Biol. Chem., 270, 24965-24971 (1995)   DOI   ScienceOn
139 Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C., and Pezzuto, J. M., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220 (1997)   DOI   PUBMED
140 Park, J. W., Choi, Y. J., Suh, S. I., and Kwon, T. K., Involvement of ERK and protein tyrosine phosphatase signaling pathways in EGCG-induced cyclooxygenase-2 expression in Raw 264.7 cells. Biochem. Biophys. Res. Commun., 286, 721-725 (2001)   DOI   ScienceOn
141 Harris, R. E., Alshafie, G. A., Abou-Issa, H., and Seibert, K., Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res., 60, 2101-2103 (2000)
142 Subbaramaiah, K., Zakim, D., Weksler, B. B., and Dannenberg, A. J., Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc. Soc. Exp. Biol. Med., 216, 201-210 (1997)
143 Surh, Y.-J., Cancer chemoprevention with dietary phytochemicals. Nature Rev. Cancer, 3, 768-780 (2003)   DOI   PUBMED   ScienceOn
144 Kim, S. O., Kundu, J. K., Shin, Y., Park, J.-H., Cho, M.-H., Kim, T.-Y., and Surh, Y.-J., [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-${\kappa}$B in phorbol ester-stimulated mouse skin. Oncogene, in press (2005)   DOI   ScienceOn
145 Chen, C. W., Lee, S. T., Wu, W. T., Fu, W. M., Ho, F. M., and Lin, W. W., Signal transduction for inhibition of inducible nitric oxide synthase and cyclooxygenase-2 induction by capsaicin and related analogs in macrophages. Br. J. Pharmacol., 140, 1077-1087 (2003)   DOI   ScienceOn
146 Greenberg, E. R., Baron, J. A., Freeman, D. H., Jr., Mandel, J. S., and Haile, R., Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J. Natl. Cancer Inst., 85, 912-916 (1993)   DOI   ScienceOn